Legal Representation
Attorney
Bassam N. Ibrahim
USPTO Deadlines
Next Deadline
4 days remaining
Published for Opposition
Due Date
January 22, 2026
Extension Available
Until February 22, 2026
Application History
19 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 23, 2025 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 23, 2025 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 17, 2025 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Nov 28, 2025 | ERRR | O | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | Loading... |
| Nov 18, 2025 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Oct 21, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 21, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 21, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Aug 13, 2025 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Aug 13, 2025 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Aug 13, 2025 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Aug 12, 2025 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jul 30, 2025 | MDSC | E | NOTICE OF DESIGN SEARCH CODE E-MAILED | Loading... |
| Jul 30, 2025 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jul 10, 2025 | AMPX | O | PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | Loading... |
| Jul 10, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Jun 30, 2025 | PARI | I | TEAS VOLUNTARY AMENDMENT RECEIVED | Loading... |
| Jun 13, 2025 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jun 13, 2025 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for the treatment and prevention of cardiovascular disease, stroke, dyslipidemia, thrombosis, hyperphosphatemia, diabetes, cancer, oncological disease, leukemia, metastasis, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, osteoporosis, age-related macular degeneration, kidney disease
Additional Information
Design Mark
The mark consists of two stylized intersected triangle designs inside of and crossing the left side of a stylized orange circle design. The first triangle design appears in light purple and dark purple and the other one appears in light orange and dark orange. The color white in the mark represents background, outlining, shading and/or transparent area and is not part of the mark.
Color Claim
The color(s) light purple, dark purple, light orange and dark orange is/are claimed as a feature of the mark.
Classification
International Classes
005